4.3 Protein-Calorie Malnutrition & Endocrine Emergencies

4.3 Protein-Calorie Malnutrition & Endocrine Emergencies

Quick Summary: Nutritional deficiencies and acute endocrine emergencies represent high-acuity, high-scrutiny conditions on the AHIMA CCS examination. Coders must navigate the severity hierarchy of protein-calorie malnutrition (categories E40–E46), master the clinical documentation integrity (CDI) requirements separating physician documentation from dietitian notes, understand how recognized ASPEN/AND and GLIM frameworks may inform clinical-validation review without replacing provider documentation, and accurately classify acute endocrine crises.

---

Protein-Calorie Malnutrition Categories (E40–E46)

Protein-calorie malnutrition (PCM) occurs when metabolic demand outpaces nutrient intake, leading to the depletion of lean body mass, adipose tissue, and visceral proteins.

+-------------------------------------------------------------------------+
|               MALNUTRITION SEVERITY & MS-DRG HIERARCHY                  |
+-------------------------------------------------------------------------+
| E40: Kwashiorkor (Severe protein deficiency with nutritional edema) [MCC|
+-------------------------------------------------------------------------+
| E41: Nutritional Marasmus (Severe calorie deficiency without edema) [MCC|
+-------------------------------------------------------------------------+
| E42: Marasmic Kwashiorkor (Combined severe wasting and edema) [MCC]     |
+-------------------------------------------------------------------------+
| E43: Unspecified Severe Protein-Calorie Malnutrition [MCC]              |
| - Severe malnutrition NOS, severe nutritional deficiency                |
+-------------------------------------------------------------------------+
| E44.0: Moderate Protein-Calorie Malnutrition [CC]                       |
+-------------------------------------------------------------------------+
| E44.1: Mild Protein-Calorie Malnutrition [CC]                           |
+-------------------------------------------------------------------------+
| E46: Unspecified Protein-Calorie Malnutrition [CC]                      |
| - Malnutrition NOS, protein-calorie malnutrition NOS                    |
+-------------------------------------------------------------------------+

1. MS-DRG Financial & Quality Impact

• E43 as an MCC: Code E43 (Unspecified severe protein-calorie malnutrition) is designated as a Major Complication/Comorbidity (MCC). When reported as a supported secondary diagnosis, E43 may establish an MCC tier in an eligible MS-DRG family after exclusions and other grouper logic.
• E44.0, E44.1, E46 as CCs: Moderate, mild, and unspecified malnutrition function as Complications/Comorbidities (CCs).

2. Clinical Documentation Integrity: Physician vs. Dietitian

• Official Coding Guidelines (Section I.B.14): Code assignment for Body Mass Index (BMI, category Z68), pressure ulcer stages (L89), and coma scales (R40.2-) may be based on documentation by other healthcare professionals involved in the care of the patient (e.g., Registered Dietitians, nurses, physical therapists).
• The Malnutrition Rule: However, the underlying diagnosis of malnutrition itself (E40–E46) must be explicitly documented by the treating physician/provider. A coder cannot code malnutrition based solely on a Registered Dietitian's (RD) consult or assessment unless the attending physician explicitly documents the diagnosis in the progress notes or discharge summary, or explicitly co-signs and adopts the dietitian's diagnostic statement.

---

Clinical Validation & Audit Defense (ASPEN & GLIM Criteria)

Because E43 can affect MS-DRG severity, it may be selected for clinical-validation review. Review authority, criteria, and remedies vary by Medicare, Medicare Advantage, and commercial-payer rules and contracts.

+-------------------------------------------------------------------------+
|                ASPEN / AND CONSENSUS CLINICAL CRITERIA                  |
|       (Requires >= 2 of 6 clinical characteristics for diagnosis)       |
+-------------------------------------------------------------------------+
| 1. Energy Intake Reduction:                                             |
|    - Acute: < 50% of estimated energy requirement for >= 5 days         |
|    - Chronic: < 75% of requirement for >= 1 month                       |
+-------------------------------------------------------------------------+
| 2. Unintentional Weight Loss (% of body weight):                        |
|    - Acute: > 2% in 1 week, > 5% in 1 month, > 7.5% in 3 months         |
|    - Chronic: > 5% in 1 month, > 7.5% in 3 months, > 10% in 6 months    |
+-------------------------------------------------------------------------+
| 3. Loss of Muscle Mass (Sarcopenia / Wasting):                          |
|    - Temporal wasting, clavicular hollowing, hollow interosseous muscles|
+-------------------------------------------------------------------------+
| 4. Loss of Subcutaneous Fat:                                            |
|    - Loss of orbital fat pads, prominent ribs, hollow buccal fat pads   |
+-------------------------------------------------------------------------+
| 5. Fluid Accumulation / Edema:                                          |
|    - Generalized or localized nutritional edema masking weight loss     |
+-------------------------------------------------------------------------+
| 6. Measurably Reduced Functional Status:                                |
|    - Reduced handgrip dynamometry strength                              |
+-------------------------------------------------------------------------+

These are commonly used characteristics and illustrative severe thresholds for the stated etiologic contexts. Apply the complete current framework adopted by the organization, including the correct etiology and timeframe; the assessment supports but does not replace the accountable provider’s diagnosis.

1. GLIM Criteria (Global Leadership Initiative on Malnutrition)

GLIM requires a two-step model: at least 1 Phenotypic Criterion (non-volitional weight loss, low BMI using age- and population-appropriate cutoffs, or reduced muscle mass) AND at least 1 Etiologic Criterion (reduced food intake/assimilation, or disease burden/inflammatory condition).

2. Audit Defense Essentials

To withstand an audit, the coder and CDI specialist should ensure the chart contains:

1. A documented clinical nutrition plan (e.g., high-protein oral nutritional supplements, enteral tube feeding, or parenteral nutrition TPN).
2. Serial body weight measurements reflecting documented weight loss percentages.
3. Physical exam findings by the clinician noting severe muscle wasting or loss of adipose tissue.

Acute Endocrine Emergencies

Endocrine crises are acute, life-threatening metabolic derangements requiring immediate medical intervention.

1. Thyroid Storm / Thyrotoxic Crisis (Subcategory E05.x1)

• Definition: Extreme, life-threatening exacerbation of thyrotoxicosis manifested by hyperpyrexia ($>104^\circ\text{F}$), severe tachycardia/arrhythmias (atrial fibrillation), congestive heart failure, severe agitation, delirium, and gastrointestinal-hepatic dysfunction (Burch-Wartofsky Point Scale score $\ge 45$).
• Coding Hierarchy: In ICD-10-CM, thyroid storm is classified using 5th-character combination codes under category E05 (Thyrotoxicosis [hyperthyroidism]):
  • E05.01: Thyrotoxicosis with diffuse goiter [Graves' disease] with thyrotoxic crisis or storm
  • E05.11: Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
  • E05.21: Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm
  • E05.91: Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
• Sequencing: When a patient is admitted in thyroid storm, the E05.x1 code is sequenced as the principal diagnosis, with secondary codes assigned for cardiac manifestations (e.g., I48.91 Atrial fibrillation, I50.9 Heart failure).

2. Myxedema Coma (E03.5)

• Definition: Severe, decompensated hypothyroidism presenting with profound lethargy/coma, hypothermia ($<95^\circ\text{F}$), bradycardia, hypoventilation/hypercapnia, hyponatremia, and generalized non-pitting myxedematous edema.
• Coding Rule: Assign code E03.5 (Myxedema coma). Code E03.5 encompasses the hypothyroidism, coma, and severe hypometabolic state. Do not assign an additional baseline hypothyroidism code (E03.9).

3. Acute Adrenocortical Insufficiency / Addisonian Crisis (E27.2)

• Definition: Acute circulatory collapse and metabolic crisis due to severe cortisol and aldosterone deficiency triggered by acute physiologic stress (infection, trauma, surgery) in patients with primary adrenal insufficiency (Addison's disease) or sudden cessation of chronic high-dose corticosteroid therapy.
• Clinical Presentation: Refractory vascular hypotension/shock unresponsive to fluids and vasopressors, severe hyponatremia, hyperkalemia, hypoglycemia, fever, and acute abdominal pain.
• Coding: Assign code E27.2 (Addisonian crisis / Acute adrenocortical insufficiency). If caused by sudden withdrawal of therapeutic steroids, assign E27.2 plus T38.0X5A (Adverse effect of glucocorticoids).

4. Syndrome of Inappropriate Antidiuretic Hormone (SIADH / E22.2)

• Definition: Excessive, unsuppressed release of antidiuretic hormone (arginine vasopressin) leading to impaired water excretion, expansion of extracellular fluid volume, and euvolemic hypoosmolar hyponatremia.
• Diagnostic Criteria: Serum sodium $< 130\text{ mEq/L}$, serum osmolality $< 275\text{ mOsm/kg}$, elevated urine osmolality ($> 100\text{ mOsm/kg}$), and elevated urine sodium concentration ($> 30\text{–}40\text{ mEq/L}$) in a clinically euvolemic patient with normal thyroid and adrenal function.
• Coding: Assign E22.2 for syndrome of inappropriate secretion of antidiuretic hormone. When SIADH is associated with a malignancy, report the active malignancy as applicable and select the principal diagnosis from the circumstances of admission; malignancy-first sequencing is not automatic.

5. Diabetes Insipidus (E23.2 vs. N25.1)

• Central / Neurogenic Diabetes Insipidus (E23.2): Inadequate production or secretion of ADH from the hypothalamus/posterior pituitary (post-hypophysectomy, head trauma, pituitary tumor). Assign E23.2.
• Nephrogenic Diabetes Insipidus (N25.1): Renal tubular resistance to ADH action (e.g., chronic lithium therapy, hypercalcemia). Assign N25.1.